Literature DB >> 11891102

Tubulo-interstitial nephritis caused by sodium valproate.

Hideto Yoshikawa1, Toru Watanabe, Tokinari Abe.   

Abstract

A severely handicapped 14-year-old Japanese girl had epilepsy and was treated with sodium valproate (SV) from the age of 7 years. Although the epileptic seizures were well controlled, she sometimes had a fever and hypokalemia from the age of 13 years. Laboratory examinations revealed metabolic acidosis, hypouricemia, hypophosphatemia, glycosuria, proteinuria and aminoaciduria, thus suggesting Fanconi syndrome. Gallium scanning showed marked renal uptake. A renal biopsy revealed interstitial nephritis without immuno-deposition. SV was replaced since it was considered to be the most probable cause of the renal involvement. Thereafter, she showed marked improvement of the clinical symptoms and the laboratory data gradually, and she never had a fever. Although SV is an effective anti-epileptic drug, we have to pay attention to adverse renal effects such as Fanconi syndrome and interstitial nephritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891102     DOI: 10.1016/s0387-7604(02)00007-4

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  7 in total

1.  Risk factors for sodium valproate-induced renal tubular dysfunction.

Authors:  Satoko Koga; Takahisa Kimata; Sohsaku Yamanouchi; Shoji Tsuji; Ken Yoshimura; Atsushi Araki; Kazunari Kaneko
Journal:  Clin Exp Nephrol       Date:  2017-08-23       Impact factor: 2.801

2.  Secondary renal Fanconi syndrome caused by valproate therapy.

Authors:  Toru Watanabe; Hideto Yoshikawa; Sawako Yamazaki; Yuki Abe; Tokinari Abe
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

3.  A case of acute renal failure in a patient recently treated with clozapine and a review of previously reported cases.

Authors:  J Daniel Kanofsky; Mary E Woesner; Alexander Z Harris; James P Kelleher; Karen Gittens; Elina Jerschow
Journal:  Prim Care Companion CNS Disord       Date:  2011

4.  Vitamin U has a protective effect on valproic acid-induced renal damage due to its anti-oxidant, anti-inflammatory, and anti-fibrotic properties.

Authors:  Selda Gezginci-Oktayoglu; Ismet Burcu Turkyilmaz; Merve Ercin; Refiye Yanardag; Sehnaz Bolkent
Journal:  Protoplasma       Date:  2015-03-24       Impact factor: 3.356

5.  Influence of herbal complexes containing licorice on potassium levels: a retrospective study.

Authors:  WooSang Jung; SeungWon Kwon; JinWook Im; SeongUk Park; SangKwan Moon; JungMi Park; ChangNam Ko; KiHo Cho
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-19       Impact factor: 2.629

6.  Protective effects of fennel oil extract against sodium valproate-induced hepatorenal damage in albino rats.

Authors:  Wael M Al-Amoudi
Journal:  Saudi J Biol Sci       Date:  2016-11-05       Impact factor: 4.219

7.  Drug-Induced Lupus Secondary to Ethosuximide in Association with Acute Tubulointerstitial Nephritis and Nephrotic Syndrome.

Authors:  Rasha Aly; Xu Zeng; Kiran Upadhyay
Journal:  Pediatr Rep       Date:  2022-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.